Stock Analysis of Avenue Therapeutics Inc (ATXI) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ATXI
Close 3.95
Change -0.0500 / 1.25 %
Volume 50646.00
Vol Change -39120.00 / 43.58 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Excellent Stability


Fundamental View of Avenue Therapeutics Inc
PE (TTM)

-15.31

Very Poor
Price / Book

-98.74

Very Poor
Price / Sales

0

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

2352.32 K

Enterprise Value

569319

ROA (TTM)

-297.36

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

192.15 %

-10377.00 K
Debt to Equity

0

Excellent
Altman Z Score

-85.72

Very Poor
Quick Ratio

0

Poor
Cash Ratio

1.49

Indecisive


Highs/Lows of Avenue Therapeutics Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week4.51 12.42 % 0.785 % 5.973.807-May-2413-May-24
Two Week4.5147 12.51 % 2.06 % 5.973.807-May-2413-May-24
One Month10.1625 61.13 % 1.91 % 10.53.815-Apr-2413-May-24
Three Month10.845 63.58 % 5.42 % 15.03.808-Mar-2413-May-24
Six Months14.79 73.29 % 18.36 % 26.46753.804-Jan-2413-May-24
One year79.875 95.05 % 26.61 % 93.753.814-Jul-2313-May-24
Two year380.25 98.96 % 29.76 % 1248.753.804-Oct-2213-May-24
Five year5130.0 99.92 % 85.69 % 93.750.085214-Jul-2325-Apr-24


Technical View of Avenue Therapeutics Inc
RSI

26.74

Mild Bearish
MACD

-1.74

Bearish
ADX

31.67

Mild Bearish
Super Trend

6.61

Mild Bearish
Williams %R

-97.12

Mild Bullish
CCI

-80.27

Bullish


EMA 5

4.19

Mild Bearish
EMA 15

5.49

Mild Bearish
EMA 50

8.65

Strong Bearish
EMA 100

13.52

Strong Bearish
SMA 100

10.65

Strong Bearish
SMA 200

26.79

Strong Bearish
SMA 5 / 20

4.14 / 6.54

Mild Bearish
SMA 15 / 50

5.41 / 9.62

Strong Bearish
SMA 50 / 200

9.62 / 26.79

Mild Bearish




Charts of Avenue Therapeutics Inc


Returns of Avenue Therapeutics Inc with Peers
Period / StockATXIGMDABPTSSNOA
1 Week-12.42%-43.73%-36.96%-1.19%
1 Mth-61.13%-94.64%-45.32%-14.53%
3 Mth-63.58%-94.95%-58.06%-3.23%
6mth-73.29%-97.61%-77.42%-4.21%
1 Year-95.05%-98.81%-93.94%-84.57%
2 Year-98.96%-99.32%-98.75%-95.64%
5 Years-99.92%-99.79%--98.00%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Avenue Therapeutics Inc with Peers
Ratio / StockATXIGMDABPTSSNOA
PE-15.31-7.55-31.69-0.190
P/B-98.74-46.01-43.040.145
ROA-297.36-56.01-24.66-34.16
ROE000-76.57
Debt To Equity0-27.40-1.920.086
Revenue0
% 		673000
% 		0
% 		13272.00 K
5.10 %
Net Income-10377.00 K
192.15 % 		-76951.00 K
50.15 % 		-17026.00 K
29.69 % 		-5217.00 K
2.58 %


Technicals of Avenue Therapeutics Inc with Peers
Technical / StockATXIGMDABPTSSNOA-
ADX31.6731.1010.1423.50
CMF-0.561-0.2640.113-0.283
MFI56.5529.3683.6147.31
RSI26.7421.5931.1745.94
MACD Abv SignalFalseFalseFalseFalse
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Avenue Therapeutics Inc

Address : 1111 Kane Concourse, Tampa, FL, United States, 33154
Tel : 781 652 4500
URL : https://www.avenuetx.com
Code : ATXI, ISIN : US05360L3042, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 27_Jun_2017
Employee Count : 3

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.


Note : All Data Generated at the End of Trading Hours (EOD Data)